Innovation in Regulatory Science
Burroughs Wellcome Fund is offering a funding call in United States. Applications close on Feb 11, 2027. What it covers is set out below in the issuer's own words.
At a glance
- Type
- Funding
- Offered by
- Burroughs Wellcome Fund (Private funding)
- Where
- United States
- Value
- $500,000 over five years
- Closes
- Feb 11, 2027
- How to apply
- On the issuer's own website
In the issuer's words
UPDATE: BWF is hosting a webinar for investigators interested in applying for the Innovation in Regulatory Science Award (IRSA). In this webinar, participants will get an overview of the 2026-2027 RFP and learn more about the application process, eligibility criteria, and award components. Interested participants can find webinar details and register using this link .
The Burroughs Wellcome Fund (BWF) recognizes Regulatory Science as an important yet underfunded area of research. Regulatory science includes the development and evaluation of new tools, standards, and approaches used to assess the safety, efficacy, quality, and performance of products and interventions that affect human health. Regulatory science has become an increasingly important component of fostering innovation while maintaining public trust and protecting patients/consumers/the public. Through this initiative, BWF aims to stimulate innovation in this area and strengthen the evidence needed to support regulatory decision-making.
BWF’s Innovation in Regulatory Science Awards provides $500,000 over five years to academic researchers developing innovative tools, standards, and approaches in regulatory science that will ultimately inform regulatory decisions made by the FDA, Health Canada, and/or other regulatory or standards-setting bodies responsible for protecting human health and safety. Responsive projects may address regulatory questions involving traditional therapeutics, biologics, and devices; BWF will also consider projects involving diagnostics, food, consumer products, or other areas affecting human health and safety, provided that the work develops an innovative approach to address a clearly defined and important regulatory science problem, and a strong case is made regarding its potential to impact human health significantly.
The following video was recorded in 2023 and is being shared for informational purposes because it contains a wealth of information about the IRSA program. Note that some deadlines in the videos refer to past award cycles.
Progress and financial reports are required of all BWF grants and are due on the date(s) specified in the award letter or agreement. The Advisory Committee and staff depend heavily upon progress and financial reports to evaluate progress. Late reports inconvenience advisory committee reviewers and impede BWF's evaluation of its programs. Failure to submit progress or financial reports in a timely fashion will result in payments being withheld, and if submissions are missed repeatedly, the award will be terminated.
BWF provides the following progress report guidelines to assist in preparing and submitting progress reports in an acceptable manner. The progress report and financial updates are to be submitted through Proposal Central . You can find the required deliverables listed on the home page after logging in to Proposal Central. Failure to submit any portion of the report by the due date will result in an interruption or cancellation of your funds.
If you need help using Proposal Central, please follow the instructions on their Customer Service webpage to contact their tech support team.
Awardees may request a no-cost extension (i.e., no additional grant funds to be provided) at least 30 days before the grant end date. To begin a no-cost extension request, please email our Program Associate, Eliza Gary ( egary@bwfund.org ) with a short description of the purpose for which the extension is requested. The request for a no-cost extension must be copied to the investigator and the appropriate representative of the investigator’s institution. The BWF team will then add an official no-cost extension request to your award on Proposal Central; there, the awardee should include a detailed explanation of the purposes for which the extension is requested. Directions are outlined in the award contract/agreement “General Terms and Conditions” and included in Proposal Central.
In general, extensions do not exceed 24 months. The Fund reserves the right to deny a request in whole or in part. If the request is approved, it will be incumbent upon the named investigator and his/her institution to provide annual progress and expenditure reports each year of the no-cost extension period and final progress and financial reports at the end of the no-cost extension period. BWF will request a return of all no-cost extension funds if progress report requirements and deadlines are unmet.
Progress Report
The progress report requires the awardee to submit a written report on the progress of the original or approved update to research project aims, an updated biographical sketch, a summary of research progress, and any recent publications. Details regarding each section are in Proposal Central. The progress report must be submitted annually on November 1st.
Financial Report
Awardees are required to update award spending in the Proposal Central budget summary; awardees should report spending in the “expenses” column. Details regarding financial reporting are in Proposal Central. Financial reports are due annually on November 1st.
Report Format
All progress and financial reporting materials should be submitted through Proposal Central. If you have questions, please contact our Program Coordinator, Lama Haidar ( lhaidar@bwfund.org ).
Can I contact BWF to determine my eligibility?
Applicants are responsible for reading the published guidelines and FAQs to determine eligibility. The FAQs are updated regularly in response to questions received. BWF staff will do their best to respond to every inquiry but will prioritize questions not already clearly addressed in the published guidelines. Please do not contact BWF to ask if we can make an exception to clearly stated guidelines. To ensure a timely response, please email your questions to the program contacts provided.
What are the research priority areas for this program?
More from Burroughs Wellcome Fund
- Career Guidance for Trainees Burroughs Wellcome Fund
- Career Guidance for Trainees Burroughs Wellcome Fund
- Innovation in Regulatory Science Burroughs Wellcome Fund
- Postdoctoral Enrichment Program Burroughs Wellcome Fund
- Postdoctoral Enrichment Program Burroughs Wellcome Fund
Similar offers in United States
- University Nuclear Leadership Program– Scholarship and Fellowship Support Idaho Field Office
- Staff Research Program Dept of the Army -- Materiel Command
- Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) National Institutes of Health
- Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) National Institutes of Health
- US Army Combat Capabilities Development Command Broad Agency Announcement ACC APG - Natick
- Defense Security Cooperation University - Research Grants Washington Headquarters Services